why choose us

First received: November 11, 2022

Clinical Trial: MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

Study Status: Completed

Recruit Status: Completed

Condition: Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

Study Type: Interventional


Official Title: MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

Brief Summary: In a randomized, placebo-controlled trial, 35 patients with HIBI were randomly designated to receive either MLC901 or placebo capsules over six months.We evaluated patients in two groups by modified Rankin Scale (mRS) and Glasgow outcome scale (GOS) to examine their state of disability and recovery

Read more